Skip to the page

Data / Drug companies / Menper Distributors, Inc.

Menper Distributors, Inc.: 39 products in the FDA NDC directory, labeler code 53145

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Menper Distributors, Inc. (labeler code 53145) lists 39 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 39 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 1, 2026.

The request: Watch Menper Distributors, Inc. (FDA labeler code 53145): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
53145
Products in commercial distribution
39
Packages
43
Finished drugs by generic name
25
Prescription products
0
Over the counter products
39
Flagged as original packager
39 of 39 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
January 18, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs39100%

Products by type

TypeProductsShare
Over the counter drugs39100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Methyl salicylate524
Undecylenic acid338
Acetaminophen3214
Dextromethorphan hbr, guaifenesin, phenylephrine hcl228
Guaifenesin, dextromethorphan21
Sodium bicarbonate251
Acetaminophen, diphenhydramine hcl, phenylephrine hci11
Pyrethrum extract, piperonyl butoxide11
Bismuth subsalicylate180
Guaifenesin, dextromethorphan hbr126
Camphor, menthol, eucalyptus oil112
Dextromethorphan hbr, guaifenesin167
Pyrantel pamoate113
Dextromethorphan hydrobromide, guaifenesin149
Dextromethorphan, guiafenesin, phenylephrine11
Dextromethorphan, guaifenesin15
Undecylenic acid, zinc undecylenate11
Phenol131
Benzocaine1110
Carbamide peroxide137
Magnesium sulfate heptahydrate120
Menthol1263
Neomycin sulfate112
Acetaminophen, chlorpherinamine maleate, phenylephrine hci11
Dextromethorphan hbr, phenylephrine hcl12

Dosage forms

Dosage formProductsShare
Liquid1948.7%
Ointment615.4%
Tablet410.3%
Spray37.7%
Shampoo12.6%
Suspension12.6%
Solution12.6%
Oil12.6%
Powder12.6%
Crystal12.6%
Gel12.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Duralgina Extra Strength53145-830TabletOver the counter monograph drugsJune 1, 2026
BeeVenom53145-315OintmentOver the counter monograph drugsApril 1, 2026
Sal Inglesa EPSOM SALT53145-580CrystalOver the counter monograph drugsJuly 1, 2025
Adult Bisolvine Adult53145-323LiquidOver the counter monograph drugsMay 1, 2025
Mucosan Severe Multi-Symptom53145-697LiquidOver the counter monograph drugsNovember 1, 2024
Mucosan Max with Acetaminophen53145-696LiquidOver the counter monograph drugsNovember 1, 2024
Mucosan Multi-Symptom Honey53145-695LiquidOver the counter monograph drugsNovember 1, 2024
Mucosan Multi-Symptom Cherry53145-693LiquidOver the counter monograph drugsNovember 1, 2024
Mucosan Childrens Multi-Symptom Grape53145-691LiquidOver the counter monograph drugsNovember 1, 2024
Viva Porru Chest Rub53145-707OintmentOver the counter monograph drugsJanuary 1, 2024
Defensol D Blister Pack53145-009TabletOver the counter monograph drugsJanuary 1, 2024
Bismutina53145-475LiquidOver the counter monograph drugsApril 1, 2021
Abejas y Viboras Roll On53145-705LiquidOver the counter monograph drugsMarch 31, 2021
Hongocura S53145-319SprayOver the counter monograph drugsApril 6, 2020
Hongocura M53145-219SprayOver the counter monograph drugsApril 6, 2020
Berro y Cebolla DM53145-080LiquidOver the counter monograph drugsApril 1, 2019
Bisolvine Aloe-Miel53145-402LiquidOver the counter monograph drugsJanuary 1, 2019
Hongocura53145-017OintmentOver the counter monograph drugsOctober 9, 2018
Sodium Bicarbonate Antacid53145-390PowderOver the counter monograph drugsJanuary 1, 2017
Duralgina53145-013TabletOver the counter monograph drugsJanuary 1, 2017
Defensol-ito53145-333SolutionOver the counter monograph drugsJanuary 1, 2014
Auralyt53145-311LiquidOver the counter monograph drugsJanuary 1, 2014
Anestenka53145-301LiquidOver the counter monograph drugsJanuary 1, 2014
Liendrex53145-308ShampooOver the counter monograph drugsJanuary 1, 2013
Parasitol53145-101SuspensionOver the counter monograph drugsJanuary 1, 2013

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.